CFPCLearn
Al Dosterone, a 54 year old man presenting with difficult to control blood pressure
info_outlineCFPCLearn
Olive Peloponnese, a 50 year old woman with coming in to review her “bad cholesterol.”
info_outlineCFPCLearn
Per Colate, Part II, a 72 year old man presenting with ongoing symptoms of nocturia and urinary frequency
info_outlineCFPCLearn
Rusty Malassez, a 62 year old presenting with rash on face and chest.
info_outlineCFPCLearn
In episode 606, Jamie and James go over the best available evidence we have for the medications used in overactive bladder, with a focus on a newer agent mirabegron. We end up having to discuss the exciting topics of number of voids and dry mouth and at the end we give you all the numbers you need to have an evidence-based conversation with your patients. Show Notes 1) Tools For Practice 2)
info_outlineCFPCLearn
In episode 605, James and Jamie get Emelie Braschi to answer a simple and common clinical question. ASA versus direct oral anticoagulants – which one is safer with regard to bleeding? As always it comes down to the numbers and we go over all those numbers and put them into the overall benefit and harm ratio for Afib. Show Notes 1) Tools For Practice 2) 3)
info_outlineCFPCLearn
In episode 604, James and Mike K get Jennifer Young to tackle the topic of nose bleeds and what the evidence shows around the use of topical tranexamic acid and how it compares to other treatments. We go over all the endpoints and give you all the numbers. Show Notes 1) Tools For Practice 2)
info_outlineCFPCLearn
In episode 603, James and Mike K invite Jennifer Young back to the podcast to talk about the best available evidence for topical minoxidil and hair growth. We discuss outcomes such as the numbers of hairs per squared centimeter – the main outcome reported – but when available, we also other report on other outcomes and also the side effects. So, if you want to know about numbers of hair per squared centimeter and all the other numbers, tune in. Show Notes 1) Tools For Practice 2)
info_outlineCFPCLearn
Vous êtes toujours parmi nous? La fin approche! Dans ce 47ème épisode du Pharmascope et dernier de la série sur le TDAH, Nicolas, Isabelle et leur invitée discutent entre autres des options de traitement pharmacologiques autres que les psychostimulants. Les objectifs pour cet épisode sont : Comprendre les risques et les bénéfices associés à la prise de l’atomoxetine et de la guanfacine Évaluer la place de l’atomoxetine et la guanfacine dans l’algorithme de traitement du TDAH Adapter le traitement pharmacologique du TDAH en fonction du patient Ressources...
info_outlineCFPCLearn
Restez concentrés parce que ce n’est pas terminé! Après un premier épisode sur le diagnostic et la prise en charge non-pharmacologique du TDAH, on porte cette fois toute notre attention sur les pilules. Dans ce 46ème épisode du Pharmascope, Nicolas, Isabelle et leur invitée discutent donc du traitement pharmacologique du TDAH, plus spécifiquement des psychostimulants. Les objectifs pour cet épisode sont : Identifier les différentes formulations de psychostimulants disponibles dans le traitement du TDAH Comprendre les risques et les bénéfices associés à la prise de...
info_outlineIn this episode of In the Clinic, Mike and Jess invite back Dr. Jennifer Young. The team discusses Benazir Pervez, a 17-year-old female coming in for acne.